A self-renewal program controls the expansion of genetically unstable cancer stem cells in pluripotent stem cell-derived tumors

Stem Cells

Volumn 27, Issue 1, 2009, Pages 18-28

  Conway, Anne E ^a   Lindgren, Anne ^a   Galic, Zoran ^a,b   Pyle, April D ^a,b   Wu, Hong ^a,b   Zack, Jerome A ^a,b   Pelligrini, Matteo ^a   Teitell, Michael A ^a,b   Clark, Amander T ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

Embryonal carcinoma; Embryonic stem cells; Germ line; Retinoic acid

Indexed keywords

RETINOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER STEM CELL; CARCINOGENESIS; CELL EXPANSION; CELL RENEWAL; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE REARRANGEMENT; GERM CELL TUMOR; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KARYOTYPING; METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE; PLURIPOTENT STEM CELL; PRIMARY TUMOR; SOLID TUMOR; TESTIS TUMOR;

ANIMALS; ANTIGENS, CD15; CELL LINE; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; GENOMIC INSTABILITY; GERM CELLS; HUMANS; MALE; MICE; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLURIPOTENT STEM CELLS; TESTICULAR NEOPLASMS; TRETINOIN;

MURINAE; MUS;

EID: 59849095153     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2008-0529     Document Type: Article

References (75)

1. Simmonds P, Lee A, Thaeker J et al. Primary pure teratoma of the testis. J Urol 1996;155:939-942.
2. Pera M, Cooper S, Mills J et al. Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. Differentiation 1989;42:10-23.
3. Pera MF, Blasco-Lafita MJ, Cooper S et al. Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells. Differentiation 1988;39:139-149.
4. Pera MF, Blasco Lafita MJ, Mills J. Cultured stem-cells from human testicular teratomas: The nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma. Int J Cancer 1987;40:334-343.
5. Prokhorova TA, Harkness LM, Frandensen U. Teratoma formation by human embryonic stem cells is site-dependent and enhanced by the presence of Matrigel. Stem Cells Dev 2008 [Epub ahead of print].
6. Clark A. The stem cells of testicular cancer. Stem Cell Reviews 2007;3:49-59.
7. Hoei-Hansen C, Alumstrup K, Nielsen J et al. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumors. Histopathology 2005;47:48-56.
8. Cheng L. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer 2004;101:2006-2010.
9. Skotheim RI, Lind GE, Monni O et al. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 2005;65:5588-5598.
10. ISCI. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25:803-816.
11. Almstrup K, Hoei-Hansen CE, Wirkner U et al. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 2004;64:4736-4743.
12. Kimura T, Suzuki A, Fujita Y et al. Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 2003;130:1691-1700.
13. Looijenga L, Gills A, Stoop H et al. Chromosomes and expression in human testicular germ cell tumors: Insight into their cell of origin and pathogenesis. Ann NY Acad Sci 2007;1120:187-214.
14. Gillis A, Stoop H, Hersmus R et al. High-throughput microRNAome analysis in human germ cell tumours. J Pathol 2007;213:319-328.
15. Giuliano C, Kerley-Hamilton J, Bee T et al. Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochem Biophys Acta 2005;1731:48-56.
16. Maldonado-Saldivia J, van den Bergen J, Krouskos M et al. Dppa2 and Dppa4 are closely linked SAP motif genes restricted to pluripotent cells and the germ line. STEM CELLS 2007;25:19-28.
17. Stevens L. Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst 1967;549-552.
18. Koubova J, Menke D, Shou Q et al. Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proc Natl Acad Sci U S A 2006;103:2474-2479.
19. Kerr CL, Hill CM, Blumenthal PD et al. Expression of pluripotent stem cell markers in the human fetal testis. STEM CELLS o2008;26:412-421.
20. Yamaguchi S, Kimura H, Tada M et al. Nanog expression in mouse germ cell development. Gene Expr Patterns 2005:639-646.
21. Schöler H, Ruppert S, Suzuki N et al. New type of POU domain in germ line-specific protein Oct-4. Nature 1990;344:435-439.
22. Schöler H, Dressler G, Balling R et al. Oct-4: A germ line specific transcription factor mapping to the mouse t-complex. EMBO J 1990;9:2185-2195.
23. Sato M, Kimura T, Kurokawa K et al. Identification of PGC7, a new gene expressed specifically in preimplantation embryos and germ cells. Mech Dev 2002;113:91-94.
24. Resnick JL, Bixler LS, Cheng L et al. Long-term proliferation of mouse primordial germ cells in culture. Nature 1992;359:550-551.
25. Resnick JL, Ortiz M, Keller JR et al. Role of fibroblast growth factors and their receptors in mouse primordial germ cell growth. Biol Reprod 19o98;59:1224-1229.
26. Matsui Y, Zsebo K, Hogan B. Derivation of pluripotent embryonic stem cells from murine primordial germ cells. Cell 1992;70:841-847.
27. Labosky PA, Hogan BL. Mouse primordial germ cells. Isolation and in vitro culture. Methods Mol Biol 1999;97:201-212.
28. McLaren A, Durcova-Hills G. Germ cells and pluripotent stem cells in the mouse. Reprod Fertil Dev 2001;13:661-664.
29. Durcova-Hills G, Adams IR, Barton S et al. The role of exogenous fibroblast growth factor-2 on the reprogramming of primordial germ cells into pluripotent stem cells. STEM CELLS 2006;24:1441-1449.
30. Labosky PA, Barlow DP, Hogan BL. Mouse embryonic germ (EG) cell lines: Transmission through the germline and differences in the methylation imprint of insulin-like growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines. Development 19o94;120:3197-3204.
31. Labosky PA, Barlow DP, Hogan BL. Embryonic germ cell lines and their derivation from mouse primordial germ cells. Ciba Found Symp 1994;182:157-168, discussion 168-178.
32. Shamblott MJ, Axelman J, Wang S et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A 1998;95:13726-13731.
33. Kerr CL, Hill CM, Blumenthal PD et al. Expression of pluripotent stem cell markers in the human fetal ovary. Hum Reprod 2008;23:589-599.
34. Stevens L. The Origin and Development of Testicular, Ovarian and Embryo-Derived Teratomas. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1983.
35. Reubinoff B, Pera M, Fong C-Y et al. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nature 2000;18:399-404.
36. Blum B, Benvenisty N. Clonal analysis of human embryonic stem cell differentiation in teratomas. STEM CELLS 2007;25:1924-1930.
37. Wong D, Liu H, Ridky T et al. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008;10:333-344.
38. Ben-Porath I, Thomson M, Carey V et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008;40:499-507.
39. Clark AT, Bodnar MS, Fox M et al. Spontaneous differentiation of germ cells from human embryonic stem cells in vitro. Hum Mol Genet 2004;13:727-739.
40. Cao F, Lin S, Xie X et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006;113:1005-1014.
41. Ivanova N, Dobrin R, Lu R et al. Dissecting self-renewal in stem cells with RNA interference. Nature 2006;442:533-538.
42. van Gurp RJ, Oosterhuis JW, Kalscheuer V et al. Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst 1994;86:1070-1075.
43. Ulbright T. Germ cell tumors of the gonads: A selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005;18(suppl):S61-S79.
44. Damjanov I, Andrews PW. The terminology of teratocarcinomas and teratomas [Comment]. Nat Biotechnol 2007;25:1212.
45. Lensch M, Ince TA. The terminology of teratocarcinomas and teratomas. Nat Biotechnol 2007;25:1211.
46. Damjanov I, Andrews P. The terminology of teratocarcinoma and teratomas. Nat Biotechnol 2007;25:1212.
47. Atala A, Furth M. Response to The terminology of teratocarcinomas and teratomas. Nat Biotechnol 2007;25:1211-1212.
48. Stevens L. The biology of teratomas including evidence indicating their origin from primordial germ cells. Annee Biol 1962;1:585-610.
49. Stevens L, Hummel K. A description of spontaneous congenital testicular teratomas in strain 129 mice. J Natl Cancer Inst 1957;8:719-747.
50. Rajpert-De Meyts E, Bartkova J, Samson M et al. The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 2003;111:267-278, discussion 278-279.
51. Herszfeld D, Wolvetang E, Langton-Bunker E et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotechnol 2006;24:351-357.
52. Baker D, Harrison N, Maltby E et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 2007;25:207-215.
53. Draper J, Smith K, Gokhale P et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 2003;22:53-54.
54. Wu H, Kim K, Mehta K et al. Copy number variant analysis of human embryonic stem cells. STEM CELLS 2008;26:1484-1489.
55. Bianchi N, Richard S, Pavicic W. Y chromosome instability in testicular cancer. Mutat Res 2006;612:172-188.
56. Teitell M. How to assess a stem cell genome. Nature Reports Stem Cells 2008 [Epub ahead of print].
57. Ginestier C, Hur M, Charafe-Jauffret C et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-567.
58. Duester G. Genetic dissection of retinoid dehydrogenases. Chem Biol Interact 2001;130-132:469-480.
59. Sanz M, Montesinos P, Vellenga E et al. Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: Long-term outcome of the LPA 99 multicenter study by the PETHEMA Group. Blood 2008;112:3130-3134.
60. Gordon M, Battiato L, Finch D et al. Dramatic response of teratoma-associated non-germ-cell cancer with all-trans retinoic acid in a patient with nonseminomatous germ cell tumor. Am J Clin Oncol 2001;24:269-271.
61. Kollmannsberger C, Mayer F, Kuczyk M et al. Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy. World J Urol 2001;19:120-125.
62. Luatti S, Marzocchi G, Ottaviani E et al. Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement: Clinical implications. Leuk Res 2008;32:1941-1943.
63. Kiger AA, Jones DL, Schulz C et al. Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue. Science 2001;294:2542-2545.
64. Wise T, Pravtcheva D. Delayed onset of Igf2-induced mammary tumors in Igf2r transgenic mice. Cancer Res 2006;66:1327-1336.
65. Kaneda A, Feinberg A. Loss of imprinting of IGF2: A common epigenetic modifier of intestinal tumor risk. Cancer Res 2005;65:11236-11240.
66. Dejosez M, Krumenacker J, Zitur L et al. Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell 2008;133:1162-1174.
67. Faravelli F. NSD1 mutations in Sotos syndrome. Am J Med Genet C Semin Med Genet 2005;137C:24-31.
68. Jin Y, Chen R, Wang P et al. Sacrococcygeal germ cell tumor and spinal deformity in association with Sotos syndrome. Med Pediatr Oncol 2002;38:133-134.
69. Leonard N, Cole T, Bhargava R et al. Sacrococcygeal teratoma in two cases of Sotos syndrome. Am J Med Genet 2000;95:182-184.
70. Muraishi O, Kumamaru T, Nozaki Y et al. Testicular yolk sac tumour in a patient with Sotos syndrome. BJU Int 1999;83:357-358.
71. Hochedlinger K, Yamada Y, Beard C et al. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005;121:465-477.
72. Di Cristofano A, Pesce B, Cordon-Cardo C et al. Pten is essential for embryonic development and tumour suppression. Nat Genet 1998;19:348-355.
73. Noguchi T, Noguchi M. A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testicular teratomas in 129/Sv-ter mice. J Natl Cancer Inst 1985:385-392.
74. Youngren K, Coveney D, Peng X et al. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumors. Nature 2005;435:360-364.
75. Kedde M, Strasser MJ, Boldajipour B et al. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 2007;131:1273-1286.